首页> 外文期刊>Breast care >Intracystic Papillary Carcinoma of the Breast in Males. In Search of the Optimal Treatment for this Rare Disease
【24h】

Intracystic Papillary Carcinoma of the Breast in Males. In Search of the Optimal Treatment for this Rare Disease

机译:男性乳房内囊性乳头状癌。寻找这种罕见疾病的最佳治疗方法

获取原文
获取外文期刊封面目录资料

摘要

Intracystic papillary carcinoma (IPC) of the breast in men is an extremely infrequent disease, and it appears to have a good prognosis. Because of this, histological findings are of great importance in the decision-making process regarding treatment. Clinical examination, radiological and histological assessments are required for early detection. Adequate surgical excision with negative margins is mandatory. However, the role of sentinel node biopsy has not been evaluated in male IPC. It appears that sentinel node biopsy may be an excellent alternative to radical axillary dissection in patients with IPC and associated ductal carcinoma in situ or invasive carcinoma. Nevertheless, due to the rarity of IPC and its confusing histopathological classification and staging, there are still no clear guidelines as far as IPC treatment is concerned.
机译:男性乳房内囊性乳头状癌(IPC)是一种极少见的疾病,预后良好。因此,组织学发现在有关治疗的决策过程中非常重要。早期发现需要临床检查,放射学和组织学评估。负负边缘的足够的手术切除是强制性的。但是,尚未在男性IPC中评估前哨淋巴结活检的作用。在IPC和相关导管原位癌或浸润性癌患者中,前哨淋巴结活检似乎是根治性腋窝淋巴结清扫术的绝佳替代方法。然而,由于IPC的罕见性及其令人困惑的组织病理学分类和分期,因此就IPC的治疗而言,尚无明确的指南。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号